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LETTER TO THE EDITOR
Reply to Webb et al.
To the Editor: Biallelic inheritance of MYH (MIM 604933)
defects has been consistently shown to increase risk of
colorectal disease (MIM 608456) in a number of different
populations.1–3 However, the increase in risk due to mono-
allelic inheritance is still under debate. Croitoru et al.2
alluded to a monoallelic effect, presenting indirect evi-
dence of nonrandom loss of heterozygosity of the wild-
type alleles in tumors of heterozygous patients, and they
also demonstrated an excess of familial clustering of
disease in these patients. Our previously published data3
suggested a monoallelic effect, which was statistically sig-
nificant only for later-onset disease. Rather than a “data-
dredging” exercise, the rationale for the analysis of age
subgroups was our a priori hypothesis of an age effect. We
conducted significance testing by permutation tests, be-
cause empirical significance levels are generally considered
to be more robust to violations of the underlying statistical
assumptions than are the asymptotic significance levels.
However, we recognized that this effect was of borderline
statistical significance at the 5% level, and we emphasized
that this evidence should be interpreted with caution. We
concluded that this preliminary observation merited fur-
ther study.
Since publication of that work in the Journal,3 we have
performed a replication study, using Scottish population-
based samples and a meta-analysis of all published case-
control MUTYH association studies, and this work was
recently published.4 The pooled results confirmed the
reported biallelic effect and gave more-precise estimates
of the associated risk. However, we again observed a
monoallelic effect of borderline statistical significance (OR
1.27; 95% CI 1.01–1.61). These findings are comparable
to those of the meta-analysis presented by Webb et al.,5
with additional primary data from English samples, al-
though their analysis fails to achieve statistical signifi-
cance at the 5% level (OR 1.26; 95% CI 0.99–1.60). The
overall lack of association with the MUTYH gene in the
Webb study is in contrast to the other two large association
studies with 11,000 cases and controls.2,3 Similarly, the
results of the kin-cohort study performed by Webb et al.5
is in contrast to the published work of Jenkins et al.,6 who
demonstrated a threefold increase in risk for monoallelic
carriers by use of a similar analysis. These differences may
be due to study bias and confounding due to imperfect
case-control matching, rather than to true population
differences.
Overall, we think that the available data support a small
monoallelic effect of MYH variants. However, it is clear
that meta-analysis is needed to achieve the very large sam-
ple sizes required to confirm the small effects that are
typical of such variants. A road map for this effort was
recently proposed.7 To this end, we have already invited
all other seven groups with published case-control data
on MYH variants to pool all available data, to address this
issue and to investigate evidence of age, sex, or other ef-
fects associated with tumor pathology.
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Web Resource
The URL for data presented herein is as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for MYH and colorectal disease)
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